3
Clinical Trials associated with Anti-CD30 CAR-T (Shanghai SongGe )An exploratory clinical study to evaluate the safety and efficacy of anti CD30 CAR T cell injection (anti CD30 CAR T cells) in patients with CD30+relapsed/refractory lymphoma
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells Injection (Anti CD30 CAR T Cells) in Patients With CD30+ Relapsed/Refractory Lymphoma
This is a single-center, open label, single dose study of anti CD30 CAR-T cells injection in treatment of patients with relapsed/refractory CD30+ lymphoma.
An exploratory clinical study to evaluate the safety and efficacy of anti-CD30 CAR T cell injection (anti CD30 CAR T cells) in patients with CD30+ relapsed/refractory lymphoma
100 Clinical Results associated with Anti-CD30 CAR-T (Shanghai SongGe )
100 Translational Medicine associated with Anti-CD30 CAR-T (Shanghai SongGe )
100 Patents (Medical) associated with Anti-CD30 CAR-T (Shanghai SongGe )
100 Deals associated with Anti-CD30 CAR-T (Shanghai SongGe )